Evaluating the effect of vitamin D3 supplementation on bone infection treatment and on sleep quality, anxiety and depression in patients with bone infectio
Not Applicable
Recruiting
- Conditions
- Chronic osteomyelitis.Staphylococcal infection, unspecified site
- Registration Number
- IRCT201609026026N4
- Lead Sponsor
- Kerman Univesity of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with chronic osteomyelitis in the 16-55 age range
Exclusion criteria: use of other vitamin D supplements; use of immunosuppressants; history of hypercalcemia or nephrolithiasis; sarcoidosis; kidney disorders requiring dialysis or polycystic kidney disease; cirrhosis; cancer; baseline plasma calcium (corrected for plasma albumin concentration) greater than 10.4 mg/dL or less than 8.4 mg/d
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ESR. Timepoint: At baseline, after 2 weeks and after 1, 2,3,4, 5 and 6 months. Method of measurement: Blood test.;CRP. Timepoint: At baseline, after 2 weeks and after 1, 2,3,4, 5 and 6 months. Method of measurement: Blood test.;Clinical presentations. Timepoint: At baseline, after 2 weeks and after 1, 2,3,4, 5 and 6 months. Method of measurement: Physical examination.
- Secondary Outcome Measures
Name Time Method Mental disorders. Timepoint: At baseline, after 3 and 6 months. Method of measurement: Questionnaires.